OUR WEBSITE IS CURRENTLY BEING UPDATED INCLUDING 4 NEW PRODUCT PAGES ADDED.
PLEASE KEEP ON CHECKING OUR WEBSITE
about oc farma
OC Farma is an innovative pharmaceuticals company with more than twenty years of experience in handling Business Development, Licensing and Regulatory Affairs of Original/Generic Pharmaceuticals Biosimilars, Mabs, OTCs, Cosmetics, Dermocosmetics, Dietary Supplements and Medical Devices focusing on the Turkish Market. OC Farma identifies "in need" healthcare products for In-licensing and actively manage regulatory and reimbursement approvals followed by professional sales and marketing activities.
OC Farma is committed to being a long-term partner of choice for international pharmaceutical companies . Our experienced management team has a strong track record in pharmaceutical business having worked with over 100 licensors worldwide with successful partnership executions. We are actively seeking commercialization partners to develope our portfolio of products. We also welcome collaboration possibilities and proposals for strategic alliances and in-licensing opportunities.
WHAT WE DO
Our management has vast experience and competence in manufacturing, sales and marketing, business development, licensing and regulatory business of original/reference pharmaceuticals, phytopharmaceuticals, OTCs, food/dietary supplements, cosmeceuticals and medical devices both locally and globaly.
OC Farma management has cooperated with numerous companies in the past 20 years including Nestle/Galderma (Switzerland), Anika Therapeutics (USA), Pfizer (Turkey), Sun Pharma (India), Three Rivers Pharma (Now Kadmon) (USA), Insite Vision (USA), Gynetics Inc (USA), Talecris Inc (Now Grifols)(USA), Mentor Corp (Now J&J)(USA), Mission Pharmacal (USA), Bionorica AG (Germany), Engelhard (Germany), Steigerwald (Germany), ZLB (Now CSL Behring) (Switzerland), Helsinn Healthcare (Switzerland), Almirall Prodespharma (Spain), Medac (Germany), FAES (Spain), Chemo (Spain), Bioiberica (Spain), IIP (Germany), Farmaka,(Italy), Inventia (India), Lupin (India), StatensSerum Institute (Denmark), Cilag Ag (Switzerland), Biopartners (Switzerland), Pharmalinking (Italy), Applied Strategic (UK), DongKook (Korea), Insight Agents (now AGFA) (Belgium), Lyomark (Germany), Azad Pharm,(Switzerland), Bene (Germany), Flavine (Germany), Hualan (China), Calmino (Sweden), Navamedic (now Vitaflo) (Norway), Panacea Biotech (India), Mdt (Switzerland), Disphar (Holland), Techdow (China), CelonPharma (Poland), Farmaderma (Italy), Cholestech (Now Alere)(USA), Metrika (now Bayer) (USA), LFB(France), Adivo (USA), Consultavalon(India), Pharmalink, Farmavita, Abbott, Drossapharm, Lorenz, Genpact, Mk, Neurim, Iwa.
Current partners are Faes (Spain), Cyathus (Austria), Mika (Germany), Mitelos (Spain), AEI24 (Spain), Calmino (Sweden), Lisapharma (Italy), Neosante (Portugal), Genexo (Poland), Adiuvo (Poland), Claride (Switzerland), Nagase (Japan) ,Pavia (Italy), Calao (Italy) and Stragen (Switzerland)
Business development is an important aspect for our successful and sustainable growth strategy. We continuously search for innovative products and partners to strengthen our product portfolio . For your projects, we qualify as a trustworthy and reliable partner
To find out more on our extensive network of partnerships / strategic alliances and
FOR ANY BUSINESS DEVELOPMENT AND LICENSING ENQUIRIES,
PLEASE DO NOT HESITATE TO CONTACT
OC FARMA IS A UNIQUE HEALTHCARE PROVIDER. WE FOCUS ON DELIVERING WHAT IS NOT AVAILABLE OR MEDICINE DIFFICULT TO REACH
OC FARMA ILAC AS
Eskişehir Yolu, Söğütözü Mahallesi, 2177. Sk. Blok 10-B Daire No:105 06510
Tel&Fax : +90 312 287 97 90
Email : firstname.lastname@example.org
OC FARMA 2018. All rights reserved.